Global Stem Cell Treatments for Cancer Market 2022-2028
May 2022
73
About the Report
About the Report
Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. According to market research study published by Gen Consulting Company, the global stem cell treatments for cancer market stood at around USD 2,074 million in 2021 and is projected to rise to a worth of USD 4,529 million by 2028 end, thereby garnering a CAGR of 11.8% during 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global stem cell treatments for cancer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the stem cell treatments for cancer industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the cancer type, and region. The global market for stem cell treatments for cancer can be segmented by cancer type: bone cancer, brain cancer, breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, others. In 2021, the breast cancer segment made up the largest share of revenue generated by the stem cell treatments for cancer market. Stem cell treatments for cancer market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global stem cell treatments for cancer market in 2021.
By cancer type:
- bone cancer
- brain cancer
- breast cancer
- colorectal cancer
- leukemia
- lung cancer
- melanoma
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The report explores the recent developments and profiles of key vendors in the Global Stem Cell Treatments for Cancer Market, including apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences, Inc., Celgene Corporation, ExCellThera Inc., Fluxion Biosciences, Inc., Gamida-Cell Ltd, Genexine, Inc., ImmunoCellular Therapeutics, Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals, Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group, Inc., Sphere Fluidics Limited, ViaCyte, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global stem cell treatments for cancer market.
- To classify and forecast the global stem cell treatments for cancer market based on cancer type, region.
- To identify drivers and challenges for the global stem cell treatments for cancer market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global stem cell treatments for cancer market.
- To identify and analyze the profile of leading players operating in the global stem cell treatments for cancer market.
Why Choose This Report
- Gain a reliable outlook of the global stem cell treatments for cancer market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Products
Products
Stem Cell Treatments for Cancer,
Companies
apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences Inc., Celgene Corporation, ExCellThera Inc., Fluxion Biosciences Inc., Gamida-Cell Ltd, Genexine Inc., ImmunoCellular Therapeutics Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group Inc., Sphere Fluidics Limited, ViaCyte Inc.
Table of Contents
Table of Contents
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY CANCER TYPE
- Bone cancer
- Brain cancer
- Breast cancer
- Colorectal cancer
- Leukemia
- Lung cancer
- Melanoma
- Others
PART 6. MARKET BREAKDOWN BY REGION
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
PART 7. KEY COMPANIES
- apceth Biopharma GmbH
- Benitec Biopharma Ltd.
- BioNTech SE
- Caladrius Biosciences, Inc.
- Celgene Corporation
- ExCellThera Inc.
- Fluxion Biosciences, Inc.
- Gamida-Cell Ltd
- Genexine, Inc.
- ImmunoCellular Therapeutics, Ltd.
- OncoCyte Corporation
- OncoMed Pharmaceuticals, Inc.
- Pluristem Therapeutics Inc.
- SELLAS Life Sciences Group, Inc.
- Sphere Fluidics Limited
- ViaCyte, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.